These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36524178)

  • 1. State ownership, information asymmetry and cash holding: Impact of COVID-19 on Chinese-listed firms.
    Yu D; Soh W; Noordin BAA; Yahya MH; Latif B
    Front Psychol; 2022; 13():1052979. PubMed ID: 36524178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Firms' COVID-19 Pandemic Exposure and Corporate Cash Policy: Evidence from China.
    He Z; Suardi S; Wang K; Zhao Y
    Econ Model; 2022 Nov; 116():105999. PubMed ID: 36032988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The COVID-19 outbreak and corporate cash-holding levels: Evidence from China.
    Zhou D; Zhou H; Bai M; Qin Y
    Front Psychol; 2022; 13():942210. PubMed ID: 36324775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Executive compensation controls and corporate cash holdings.
    Wang P; Zhang X; Wang T; Wan Z
    PLoS One; 2023; 18(9):e0285387. PubMed ID: 37682923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How does the data element-driven industry affect corporate cash holdings? Evidence from Chinese listed companies.
    Xiang Y; Xu M
    Heliyon; 2024 Jun; 10(12):e32737. PubMed ID: 38952370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of labor in cash holdings: Evidence from the supply-side impact of COVID-19.
    Bae J; Kang J
    Econ Lett; 2023 Mar; 224():111034. PubMed ID: 36817848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Green credit policy and corporate excess cash holdings.
    Ning J; Wang G; Xiong F; Yin S
    PLoS One; 2024; 19(1):e0294079. PubMed ID: 38227573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is cash the panacea of the COVID-19 pandemic: Evidence from corporate performance.
    Zheng M
    Financ Res Lett; 2022 Mar; 45():102151. PubMed ID: 35221815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Country risk, global uncertainty, and firms' cash holdings: Do the role of law, culture, and financial market development matter?
    Athari SA; Cho Teneng R; Çetinkaya B; Bahreini M
    Heliyon; 2024 Mar; 10(5):e26266. PubMed ID: 38463892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ESG performance, capital financing decisions, and audit quality: empirical evidence from Chinese state-owned enterprises.
    Zahid RMA; Saleem A; Maqsood US
    Environ Sci Pollut Res Int; 2023 Mar; 30(15):44086-44099. PubMed ID: 36681761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corporate payout, cash holdings, and the COVID-19 crisis: Evidence from the G-7 countries.
    Ntantamis C; Zhou J
    Financ Res Lett; 2022 Dec; 50():103275. PubMed ID: 36034341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pandemic effect on corporate financial asset holdings: Precautionary or return-chasing?
    Gao H; Wen H; Wang X
    Res Int Bus Finance; 2022 Dec; 62():101750. PubMed ID: 35996462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impacts of economic policy uncertainty on firm cash holding in China.
    Chen X; Li J; Tang D; Shang L; Boamah V; Xu J; Deng Z
    PLoS One; 2023; 18(11):e0293306. PubMed ID: 37992087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How does red culture affect corporates' cash holdings? Evidence from China.
    Li Z; Chen X; Yang B
    Heliyon; 2023 Apr; 9(4):e15435. PubMed ID: 37123901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous cash dividends, ownership structure and firm value: Evidence from Chinese A-share market.
    Qi Q; Li W; Liu C; Huang Y; Hu C
    PLoS One; 2022; 17(3):e0265177. PubMed ID: 35298495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 impact on firm investment-Evidence from Chinese publicly listed firms.
    Jiang J; Hou J; Wang C; Liu H
    J Asian Econ; 2021 Aug; 75():101320. PubMed ID: 36567767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is it good to hold more cash before the pandemic? A case of Taiwanese firms.
    Wu SW; Nguyen MT; Mai NT; Tsai JF
    Heliyon; 2023 Jun; 9(6):e16050. PubMed ID: 37260906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corporate immunity to the COVID-19 pandemic.
    Ding W; Levine R; Lin C; Xie W
    J financ econ; 2021 Aug; 141(2):802-830. PubMed ID: 34580557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environmental disclosure practices in mixed ownership models: A study of Chinese private enterprises.
    Song T; Xiong A
    PLoS One; 2023; 18(11):e0295399. PubMed ID: 38033167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of mixed-ownership reform on zombie firms: Evidence from Chinese listed SOEs.
    Yin Y; Cao K
    PLoS One; 2024; 19(7):e0301048. PubMed ID: 38959261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.